Munich, Germany headquartered contract development and manufacturing organization (CDMO) Adragos Pharma has acquired Baccinex ...

The US Food and Drug Administration (FDA) yesterday announced its Fiscal Year 2025 Generic Drug User Fee Amendments (GDUFA).

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...

UK-based drugmaker Advanz Pharma has announced that following the grant of a temporary suspension, as announced on last month ...

Kronos Bio has announced a major restructuring, including significant workforce reductions, as it grapples with clinical and ...

The European Medicines Agency has approved Tevimbra (tislelizumab) in combination with chemotherapy for advanced throat and ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...

The Down syndrome treatment market in the USA is valued at nearly $250 million, with companies like Aelis Farma, AC Immune, ...

Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed ADC for ...

The US Food and Drug Administration (FDA) has extended the review period for Soleno Therapeutics’ the New Drug Application ...